TREA

79201919 - QIASEQ

Follow

Information

  • Trademark
  • 79201919
  • Serial Number
    79201919
  • Registration Number
    5288349
  • Filing Date
    October 21, 2016
    9 years ago
  • Registration Date
    September 19, 2017
    8 years ago
  • Transaction Date
    May 07, 2024
    2 years ago
  • Status Date
    April 24, 2024
    2 years ago
  • Published for Opposition Date
    July 04, 2017
    8 years ago
  • Location Date
    April 24, 2024
    2 years ago
  • Status Code
    739
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    LAM, HAI-LY HUYNH
  • Attorney Docket Number
    10169821TR
    Attorney Name
    Victoria Friedman
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
QIASEQ
Case File Statements
  • GS0091: Scientific apparatuses, instruments and devices, as well as their structural replacement parts and components, namely, laboratory devices for detecting genetic sequences, laboratory apparatus and instruments for extracting, isolating, separating, purifying, duplicating, sequencing and/or analyzing biopolymers, in particular, nucleic acids, proteins, DNA macromolecules and biologically active substances, electrical equipment for the genetic modification of cells for research purposes; software for use in scientific and medical research, namely, software for scientific analysis of genetic sequences; software for analysis of nucleic acids, in particular software for sequencing of nucleic acids, software for extracting, isolating, separating, purifying, duplicating, sequencing and/or analyzing biopolymers, in particular, nucleic acids, proteins, DNA macromolecules and biologically active substances
  • GS0051: Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing all for medical or veterinary purposes; chemical, biochemical and biotechnological preparations, in particular reagents, enzymes and buffer solutions for medical or veterinary purposes, namely, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing all for medical or veterinary purposes; kits containing preparations of reagents, enzymes and buffer solutions for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing all for medical and veterinary diagnostic purposes
  • PM0001: QIA SEQ
  • GS0011: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use, namely, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing all for scientific or medical research use; kits comprising chemicals for sample preparation, modification and manipulation of cells for scientific purposes, other than for medical or veterinary use; kits comprising chemicals for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material all for scientific purposes, other than for medical or veterinary use; kits comprising in particular chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing for scientific purposes, other than for medical or veterinary use
Case File Event Statements
  • 2/28/2017 - 9 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/23/2017 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/24/2017 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/24/2017 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/2/2017 - 9 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/3/2017 - 9 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/4/2017 - 9 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/4/2017 - 9 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/14/2017 - 9 years ago
    9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/14/2017 - 9 years ago
    10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/25/2017 - 9 years ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/6/2017 - 9 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/21/2017 - 9 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 5/13/2017 - 9 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/13/2017 - 9 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 5/13/2017 - 9 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/23/2017 - 8 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/27/2017 - 8 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/14/2017 - 8 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/4/2017 - 8 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/4/2017 - 8 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/19/2017 - 8 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/19/2017 - 8 years ago
    23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 1/12/2018 - 8 years ago
    24 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 1/12/2018 - 8 years ago
    25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/10/2018 - 8 years ago
    26 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 5/14/2019 - 7 years ago
    27 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/19/2022 - 3 years ago
    28 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 8/30/2023 - 2 years ago
    29 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 4/23/2024 - 2 years ago
    30 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/24/2024 - 2 years ago
    31 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A
  • 4/24/2024 - 2 years ago
    32 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75